Background: Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality and a primary focus of quality improvement/patient safety efforts. VTE prophylaxis reduces the incidence of in-hospital VTE, but nonadministration rates—primarily attributed to patient refusal—often reach 10-15%. Notably, nonadministration of VTE prophylaxis may correlate with higher incidence of hospital acquired VTE. Prior studies showed [...]

Background: Venous thromboembolism (VTE) is a prevalent and costly medical condition in hospitalized patients. Risk assessment tools like the Padua Predictive Score aim to differentiate low-risk and high-risk patients for targeted pharmaceutical prophylaxis (pPPX) administration. However, widespread adoption of risk assessment remains suboptimal. This study investigates HA VTE prophylaxis use in medicine inpatients within a [...]